244 related articles for article (PubMed ID: 26054682)
1. FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infection.
Li F; Liu T; Xiao CY; Yu JX; Lu LG; Xu MY
Biomed Pharmacother; 2015 May; 72():103-8. PubMed ID: 26054682
[TBL] [Abstract][Full Text] [Related]
2. [Predication analysis of microarray data to determine altered gene profiles in liver carcinoma related to HBV-related cirrhosis].
Liu J; Zhang Q; Li Z; Zhang Q; Qu Y; Lu L; Xu M
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):625-30. PubMed ID: 25243966
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
[TBL] [Abstract][Full Text] [Related]
4. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
[TBL] [Abstract][Full Text] [Related]
5. Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis.
Liu S; Zhu P; Zhang L; Ding S; Zheng S; Wang Y; Lu F
Cancer Biomark; 2013; 13(5):345-9. PubMed ID: 24440974
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases.
Zhu C; Han H; Li J; Xu L; Liu F; Wu K; Liu X
Biomed Res Int; 2019; 2019():9321494. PubMed ID: 31240230
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.
Zhang Y; Zhang S; Wang X; Liu J; Yang L; He S; Chen L; Huang J
J Clin Pathol; 2012 Jun; 65(6):528-33. PubMed ID: 22422806
[TBL] [Abstract][Full Text] [Related]
9. Genomics of hepatitis B virus-related hepatocellular carcinoma and adjacent noncancerous tissues with cDNA microarray.
Huang YK; Fan XG; Qiu F; Wang ZM
Chin Med J (Engl); 2011 Jul; 124(13):2057-64. PubMed ID: 22088470
[TBL] [Abstract][Full Text] [Related]
10. Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patients.
Wang Q; Fiel MI; Luan W; Blank S; Kadri H; Kim KW; Hiotis SP
Ann Surg Oncol; 2013 Nov; 20(12):3761-70. PubMed ID: 23771248
[TBL] [Abstract][Full Text] [Related]
11. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
12. [Expression of CAS in hepatocellular carcinoma tissues and its relationship with HBV infection].
Zang H; Zhao JM; Ji D; Sun YL; Zhou GD; Zhao YL; Chen GF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):285-7. PubMed ID: 23189846
[TBL] [Abstract][Full Text] [Related]
13. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
14. Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker.
Marshall A; Lukk M; Kutter C; Davies S; Alexander G; Odom DT
PLoS One; 2013; 8(3):e59459. PubMed ID: 23527199
[TBL] [Abstract][Full Text] [Related]
15. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.
Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K
J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692
[TBL] [Abstract][Full Text] [Related]
16. Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.
Wang W; Zhao LJ; Wang Y; Tao QY; Feitelson MA; Zhao P; Ren H; Qi ZT
Cancer Biomark; 2011-2012; 11(1):29-39. PubMed ID: 22820138
[TBL] [Abstract][Full Text] [Related]
17. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.
Tan Y; Lin B; Ye Y; Wen D; Chen L; Zhou X
Oncol Rep; 2015 Jun; 33(6):2863-70. PubMed ID: 25962820
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
20. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
